Physician profile
Michael D Hellinger
NPI 1124084413
$1,028.62
in general payments reported to CMS, 2019-2025
13 companies · $67.88 in 2025
The $67.88 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2021: $116 · 2022: $143 · 2023: $78.99 · 2024: $256 · 2025: $67.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $321 · Gift: $81.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $320.70 |
| Gift | $81.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $173.28 | 2019-2025 | Suflave, Sutab |
| Activ Surgical, INC. | $133.90 | 2024 | Activsight |
| Medtronic, INC. | $131.17 | 2021-2023 | Interstim |
| Cook Medical LLC | $106.67 | 2019 | |
| Conmed Corporation | $95.43 | 2019-2021 | |
| Intuitive Surgical, INC. | $79.68 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $61.71 | 2021-2025 | Exparel |
| Axonics, INC. | $60.59 | 2021-2023 | Axonics |
| Smith+Nephew, INC. | $56.87 | 2019 | |
| Palette Life Sciences, INC. | $55.33 | 2022 | |
| Myriad Genetic Laboratories, INC. | $29.05 | 2023 | Myrisk |
| Abbott Laboratories | $22.67 | 2024 | Proclaim |
| Stryker Corporation | $22.27 | 2025 | Spy-Phi System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hellinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.